quinazolines has been researched along with Hypertension, Pulmonary in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (21.05) | 18.7374 |
1990's | 6 (31.58) | 18.2507 |
2000's | 3 (15.79) | 29.6817 |
2010's | 5 (26.32) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Huang, W; Kong, H; Liu, P; Peng, LY; Xie, WP; Yang, MX; Yu, M; Zhou, H | 1 |
Hohenforst-Schmidt, W; Huang, H; Kakolyris, S; Kioumis, I; Lampaki, S; Li, Q; Organtzis, J; Papaiwannou, A; Petridis, D; Pitsiou, G; Porpodis, K; Syrigos, K; Tsiouda, T; Turner, JF; Zarogoulidis, K; Zarogoulidis, P | 1 |
Li, S; Li, XW; Wang, XM; Yang, JR | 1 |
Al-Aqtash, T; Albashaireh, D; Alkhatib, Y; Awdish, R | 1 |
Banat, GA; Cornitescu, T; Dahal, BK; Dumitrascu, R; Ghofrani, HA; Grimminger, F; Kosanovic, D; Pullamsetti, SS; Schermuly, RT; Seeger, W; Tretyn, A; Voswinckel, R; Weissmann, N | 1 |
Chaumais, MC; De Man, FS; Dorfmüller, P; Eddahibi, S; Fadel, E; François, C; Girerd, B; Guignabert, C; Huertas, A; Humbert, M; Lecerf, F; Montani, D; Perros, F; Tu, L | 1 |
Jones, PL; Martinez, EC; Merklinger, SL; Rabinovitch, M | 1 |
Coma-Canella, I; Lopez-Sendon, J | 1 |
Goto, Y; Imaoka, C; Kanemoto, N | 1 |
Goto, Y; Hayashi, Y; Hojo, Y; Imaoka, C; Kanemoto, N; Ubukata, S | 1 |
Inoue, M; Mori, C; Tanaka, O; Watanabe, K | 1 |
Clarke, W; Cohen, AH; Fouty, B; Hanson, K; McMurty, IF; Morris, K; Rodman, DM | 1 |
Inoue, M; Kanda, T; Kobayashi, I; Kodama, K; Nagai, R; Suzuki, T; Takahashi, T | 1 |
Fukuchi, Y; Hanasato, N; Kira, S; Nishino, M; Oka, M; Yamaguchi, K | 1 |
Inoue, M; Iwamoto, A; Kanda, T; Kobayashi, I; Nagai, R; Sakamaki, T; Sato, K; Sumino, H; Takahashi, T | 1 |
Fukuchi, Y; Kira, S; Muramatsu, M; Ohnishi, M; Oka, M; Sato, K | 1 |
Adachi, H; Ishibashi, K; Ishihara, H; Kabasawa, Y; Kakiki, M; Kodama, K; Matsukura, M; Miyazaki, K; Nishino, M; Ozaki, H; Takase, Y; Watanabe, N | 1 |
Kakinuma, Y; Miyauchi, T | 1 |
Kunieda, T; Naito, M; Nakanishi, N; Obayashi, Y; Okubo, S; Yoshioka, T | 1 |
1 review(s) available for quinazolines and Hypertension, Pulmonary
Article | Year |
---|---|
[Endothelin receptor antagonist, phosphodiesterase inhibitor, thromboxane inhibitor].
Topics: Animals; Endothelin Receptor Antagonists; Enzyme Inhibitors; Humans; Hypertension, Pulmonary; Methacrylates; Phosphodiesterase Inhibitors; Piperidines; Purinones; Quinazolines | 2001 |
18 other study(ies) available for quinazolines and Hypertension, Pulmonary
Article | Year |
---|---|
Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
Topics: Animals; Cell Movement; Cell Proliferation; Crown Ethers; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors; Hypertension, Pulmonary; In Vitro Techniques; MAP Kinase Signaling System; Microfilament Proteins; Monocrotaline; Muscle Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteopontin; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Quinazolines; Rats; Signal Transduction; Vascular Remodeling; Ventricular Function, Right; Ventricular Pressure; Vimentin | 2020 |
Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.
Topics: Administration, Inhalation; Benzamides; Erlotinib Hydrochloride; Gefitinib; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Quinazolines | 2014 |
[Effects of rutaecarpine on right ventriclar remodeling in rats with monocrotaline-induced pulmonary hypertension].
Topics: Animals; Antioxidants; Heart Ventricles; Hypertension, Pulmonary; Indole Alkaloids; Male; Malondialdehyde; Monocrotaline; NADPH Oxidase 4; NADPH Oxidases; Quinazolines; Rats; Ventricular Remodeling | 2014 |
The role of tyrosine kinase inhibitor "Lapatinib" in pulmonary hypertension.
Topics: Aged; Antineoplastic Agents; Cardiac Catheterization; Echocardiography; Humans; Hypertension, Pulmonary; Lapatinib; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Risk Factors | 2016 |
Role of epidermal growth factor inhibition in experimental pulmonary hypertension.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Epidermal Growth Factor; Erlotinib Hydrochloride; Gefitinib; Gene Expression; Humans; Hypertension, Pulmonary; Lapatinib; Male; Mice; Muscle, Smooth, Vascular; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pulmonary Wedge Pressure; Quinazolines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Vascular Resistance | 2010 |
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.
Topics: Animals; Benzamides; Benzimidazoles; Case-Control Studies; Crk-Associated Substrate Protein; Disease Models, Animal; Endothelial Cells; Epidermal Growth Factor; Familial Primary Pulmonary Hypertension; Fibroblast Growth Factor 2; Gefitinib; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Mice; Monocrotaline; Myocytes, Smooth Muscle; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pulmonary Artery; Pyrimidines; Quinazolines; Quinolones; Rats; Signal Transduction | 2012 |
Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension.
Topics: Animals; Apoptosis; Enzyme Inhibitors; ErbB Receptors; Hypertension, Pulmonary; Integrin alphaVbeta3; Male; Metalloproteases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Culture Techniques; Protease Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Tyrphostins | 2005 |
Haemodynamic effects of nifedipine, nitroglycerine and prazosin in pulmonary hypertension following ingestion of toxic oil.
Topics: Adolescent; Adult; Child; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nifedipine; Nitroglycerin; Oils; Oxygen; Partial Pressure; Prazosin; Quinazolines | 1983 |
A case of primary pulmonary hypertension treated with prazosin and isosorbide dinitrate.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hypertension, Pulmonary; Isosorbide Dinitrate; Prazosin; Quinazolines; Vascular Resistance | 1984 |
[Primary pulmonary hypertension in a brother and a sister--combined administration of prazosin and isosorbide dinitrate].
Topics: Adult; Drug Combinations; Female; Humans; Hypertension, Pulmonary; Isosorbide Dinitrate; Male; Prazosin; Quinazolines | 1983 |
The effect of bunazosin on monocrotaline-induced pulmonary hypertension in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Hemodynamics; Hypertension, Pulmonary; Monocrotaline; Quinazolines; Rats; Rats, Sprague-Dawley | 1994 |
Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Calcium Channel Blockers; Cyclic GMP; Diltiazem; Hemodynamics; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Male; Nitric Oxide; Perfusion; Phosphodiesterase Inhibitors; Piperidines; Pulmonary Circulation; Purinones; Quinazolines; Rats; Rats, Sprague-Dawley; Vasodilation | 1996 |
A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
Topics: Animals; Disease Models, Animal; Heart Ventricles; Hypertension, Pulmonary; Male; Monocrotaline; Organ Size; Phosphodiesterase Inhibitors; Piperidines; Pulmonary Artery; Quinazolines; Rats; Rats, Wistar | 1996 |
[E 4021, a cGMP phosphodiesterase inhibitor, is a selective pulmonary vasodilator in chronically hypoxic pulmonary hypertensive rats].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Pressure; Chronic Disease; Hypertension, Pulmonary; Hypoxia; Lung; Male; Phosphodiesterase Inhibitors; Piperidines; Pulmonary Artery; Quinazolines; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1998 |
Type V phosphodiesterase inhibition modulates endogenous immunoreactivities of endothelin-1 and endothelial nitric oxide synthase in pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Immunohistochemistry; Male; Monocrotaline; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pulmonary Artery; Quinazolines; Rats; Rats, Wistar; Receptors, Endothelin | 1998 |
E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilator effect of inhaled nitric oxide in isolated perfused rat lungs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Inhalation; Animals; Bronchodilator Agents; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Synergism; Hypertension, Pulmonary; In Vitro Techniques; Isoproterenol; Lung; Male; Nitric Oxide; Nitroprusside; Perfusion; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pulmonary Circulation; Quinazolines; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasodilation | 1999 |
4-(3-Chloro-4-methoxybenzyl)aminophthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antihypertensive Agents; Biological Availability; Blood Pressure; Coronary Vessels; Cyclic Nucleotide Phosphodiesterases, Type 5; Dinoprost; Hypertension, Pulmonary; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phthalazines; Piperidines; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Swine; Vasodilator Agents | 2000 |
Effects of selective alpha 1-adrenoceptor blockade in dogs with hypoxic pulmonary vasoconstriction.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Gas Analysis; Dogs; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Pulmonary Circulation; Quinazolines; Vasoconstriction | 1988 |